North Star Asset Management Inc

Source: SEC Form 13F · as of Mar 2026

North Star Asset Management Inc holds 29 biotech & pharma companies tracked by BioSniper, totaling $147.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$147.6M

CompanySharesValue
ABBVAbbVie Inc.157,128$34.2M
ABTABBOTT LABORATORIES326,779$33.6M
PBHPrestige Consumer Healthcare Inc.211,824$12.6M
LLYELI LILLY & Co11,581$10.7M
RGENREPLIGEN CORP83,963$9.9M
PMPhilip Morris International Inc56,928$9.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)27,333$7.4M
JNJJOHNSON & JOHNSON28,545$7.0M
MCKMcKesson Corporation4,478$3.9M
AMGNAMGEN INC10,792$3.8M
VRTXVERTEX PHARMACEUTICALS INC / MA6,859$3.1M
NVONovo Nordisk A/S41,046$1.5M
INCYIncyte Corp.14,408$1.4M
MRKMerck & Co., Inc.10,951$1.3M
IONSIONIS PHARMACEUTICALS INC16,610$1.2M
PFEPFIZER INC41,570$1.2M
IQVIQVIA Holdings Inc.6,320$1.1M
NVSNovartis AG6,221$950K
REGNREGENERON PHARMACEUTICALS, INC.737$569K
IDXXIDEXX LABORATORIES INC /DE892$501K
BMYBRISTOL MYERS SQUIBB CO7,486$454K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)8,108$447K
ALNYALNYLAM PHARMACEUTICALS, INC.1,103$365K
GILDGILEAD SCIENCES, INC.2,187$305K
AVNSAvanos Medical Inc.20,543$288K
ZBHZimmer Biomet Holdings Inc.2,965$268K
CRSPCRISPR Therapeutics AG4,525$215K
GEHCGE HealthCare Technologies Inc.2,821$201K
ATNMActinium Pharmaceuticals, Inc.20,000$20K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    North Star Asset Management Inc — Biotech 13F Holdings & Portfolio | BioSniper